Posted at 13 Nov, 14:49h in Press Release by adialpharma 0 Comments 0 Likes Share Addiction Drug Developer Adial Pharmaceuticals Receives Notice of Allowance of Canadian Patent for AD04 in Alcohol Use Disorder
Sorry, the comment form is closed at this time.